NCT06288009 Outcomes of Running Locking Suture vs Standard Running Suture in Surgical Wounds
| NCT ID | NCT06288009 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | Scarring |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-08-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
When patients have surgery on the head and face, stitches are the standard way to close the wound. Wounds always result in a scar, but doctors are always looking for ways to reduce scarring. Several studies have been done to test ways to close wounds that reduce scarring. The most commonly performed closure technique uses running sutures, where a single strand of suture is continued along the length of the wound with a series of uninterrupted stiches. However, alternative closure techniques exist such as the running locking suture, which can offer advantages such as improved tension and thus reduce post-operative complications with better aesthetic outcome. In this study, half the wound will be stitched with standard running sutures and the other half will be stitched with running locking sutures. This will allow us to see if the side with running locking sutures heals with less scarring.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Able to give informed consent themselves * Patient scheduled for cutaneous surgical procedure on the head or neck with predicted primary closure * Willing to return for follow up visit Exclusion Criteria: * Incarceration * Under 18 years of age * Pregnant Women * Unable to understand written and oral English * Wounds with predicted closure length less than 3cm
Contact & Investigator
Daniel Eisen, MD
PRINCIPAL INVESTIGATOR
University of California, Davis - Dermatology
Frequently Asked Questions
Who can join the NCT06288009 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Scarring. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06288009 currently recruiting?
Yes, NCT06288009 is actively recruiting participants. Contact the research team at jmrobb@ucdavis.edu for enrollment information.
Where is the NCT06288009 trial being conducted?
This trial is being conducted at Sacramento, United States.
Who is sponsoring the NCT06288009 clinical trial?
NCT06288009 is sponsored by University of California, Davis. The principal investigator is Daniel Eisen, MD at University of California, Davis - Dermatology. The trial plans to enroll 50 participants.